Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models

https://doi.org/10.1016/0002-9343(91)90118-HGet rights and content

Abstract

purpose: The most prevalent serious drug toxicity in the United States is increasingly recognized as gastrointestinal (GI) pathology associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs). The incidence of serious GI events (hospitalization or death) associated with NSAID use was therefore prospectively analyzed in patients with rheumatoid arthritis (RA) and patients with osteoarthritis.

patients, methods, and results: The study consisted of 2,747 patients with RA and 1,091 patients with osteoarthritis. The yearly hospitalization incidence during NSAID treatment was 1.58% in RA patients and was similar in all five populations studied. The hazard ratio of patients taking NSAIDs to those not taking NSAIDs was 5.2. The incidence in osteoarthritis may be less. The risk of GI-related death in RA patients was 0.19% per year with NSAIDs. Multivariate analyses assessing risk factors for serious GI events were performed in the 1,694 (98 with an event) RA patients taking NSAIDs at the predictive visit. The main risk factors were higher age, use of prednisone, previous NSAID GI side effects, prior GI hospitalization, level of disability, and NSAID dose. A rule is presented that allows estimation of the risk for the individual patient with RA.

conclusion: Knowledge of the risk factors for NSAID-associated gastropathy and their interrelationships provides a tool for identification of the patient at high risk and for initiation of appropriate therapeutic action.

References (33)

  • T Pincus et al.

    Taking mortality in rheumatoid arthritis seriously—predictive markers, socioeconomic status and comorbidity

    J Rheumatol

    (1986)
  • D Graham et al.

    Prevention of NSAID-induced gastric ulcer with the synthetic prostaglandin, misoprostol: a multicenter, double-blind, placebocontrolled trial

    Lancet

    (1989)
  • CP Armstrong et al.

    Non-steroidal antiinflammatory drugs and lifethreatening complications of peptic ulceration

    Gut

    (1987)
  • J Caldwell et al.

    Sucralfate therapy in non-steroidal anti-inflammatory drug-induced gastritis

    Arthritis Rheum

    (1985)
  • HE Paulus

    FDA arthritis advisory committee meeting: post-marketing surveillance of nonsteroidal anti-inflammatory drugs

    Arthritis Rheum

    (1985)
  • JH Llewellyn et al.

    Influence of age and disease state in nonsteroidal antiinflammatory drug associated gastric bleeding

    J Rheumatol

    (1988)
  • Cited by (0)

    This work was supported by a grant from the National Institutes of Health (AR21393) to ARAMIS (the Arthritis, Rheumatism, and Aging Medical Information System) and in part by a grant from Searle Laboratories.

    View full text